Comparing Kabilyte vs Kadcyla
| Kabilyte (lvp solution with potassium) | Kadcyla (ado-trastuzumab emtansine) |
|
|---|
| Kabilyte (lvp solution with potassium) | Kadcyla (ado-trastuzumab emtansine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Kabilyte may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer, Breast Cancer - Metastatic. Kadcyla may also be used for purposes not listed in this medication guide. |
||||||||
| More about Kadcyla (ado-trastuzumab emtansine) | |||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Kadcyla side effects |
|||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Kadcyla prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other lvp solution with potassium brands include: Dextrose 10% and Electrolyte No 48, Dextrose 5% And Electrolyte No. 48 Injection, Ionosol MB and 5% Dextrose, Isolyte P and 5% Dextrose, Normosol-M and 5% Dextrose, Plasma-Lyte 56, Plasma-Lyte 56 and 5% Dextrose, Plasma-Lyte and 5% Dextrose, Travert 10% and Electrolyte No2, Travert 5% and Electrolyte No2 View more |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
96 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 64 drugs are known to interact with Kabilyte:
|
A total of 292 drugs are known to interact with Kadcyla:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
February 22, 2013 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
|
N/A |
|||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
|
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.